Theo-24 - Theophylline anhydrous 400 mg / 1 Capsule 100 Capsule, Extended Release
Reference details for licensed healthcare facility review and verification.
| NDC 11 | 52244-0400-10 |
|---|---|
| Product NDC | 52244-0400 |
| Generic Drug Name | theophylline anhydrous |
| Brand Name | Theo-24 |
| Manufacturer | ENDO USA, Inc. |
| Strength | 400 mg / 1 |
| Dosage Form | Capsule |
| Drug Type | Oral |
| Package Quantity | 100 Capsule, Extended Release |
| Package Description | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (52244-400-10) |
| Active Ingredients | Theophylline Anhydrous |
| Marketing Category | ANDA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
theophylline anhydrous 400 mg / 1 Capsule is tracked under NDC 52244-0400-10 and rolls up into product family 52244-0400. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.
- Package configuration: 100 Capsule, Extended Release.
- Manufacturer: ENDO USA, Inc..
- Dosage form: Capsule.
- Family size: 1 indexed presentation.
Click a tag to refine the catalog view around this product reference.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Drug Shortage Information
Public sources show a current shortage summary for Theo-24/theophylline ER products, plus official product identification and manufacturer quality-context links.
Drug Shortage Index family
View Theophylline anhydrous in the Drug Shortage IndexCompare related NDC-level product references and family-level shortage context for Theophylline anhydrous.This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
Theo-24 - Theophylline anhydrous 400 mg / 1 Capsule 100 Capsule, Extended Release, NDC 52244-0400-10, is a ENDO USA, Inc. 400 mg / 1 capsule presentation packaged as 100 Capsule, Extended Release. Current public shortage information is available for this product reference.
NDC search formats
- Canonical NDC 11: 52244-0400-10
- Digits-only NDC 11: 52244040010
- Possible 10-digit display format: 52244-400-10 (5224440010)
Helpful product links
- Search by brand name: Theo-24
- NDC 11: 52244-0400-10
- Product family NDC: 52244-0400
- VA classification code: RE104
- VA classification code description: BRONCHODILATORS,XANTHINE-DERIVATIVE
- CMOP ID: T0304
- VUID: 4003749